These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9189231)

  • 21. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
    J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
    Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
    Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
    AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy in HIV-infected patients with Kaposi's sarcoma.
    Pechère M; Krischer J; Rutschmann OT
    Dermatology; 1997; 195(4):411-2. PubMed ID: 9529573
    [No Abstract]   [Full Text] [Related]  

  • 27. What does HIV teach us about cancer?
    Peters BS
    Clin Oncol (R Coll Radiol); 1997; 9(6):355-6. PubMed ID: 9448963
    [No Abstract]   [Full Text] [Related]  

  • 28. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
    Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
    J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal doxorubicin, cyclophosphamide, and etoposide and antiretroviral therapy for patients with AIDS-related lymphoma: a pilot study.
    Combs S; Neil N; Aboulafia DM
    Oncologist; 2006 Jun; 11(6):666-73. PubMed ID: 16794245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer agents. Unique protocol looks promising for lymphoma.
    TreatmentUpdate; 2003; 15(4):5-7. PubMed ID: 17216853
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current therapeutic strategies in AIDS-associated Kaposi sarcoma. An overview including results of a personal study].
    Mauss S; Szelényi H; Jablonowski H
    Med Klin (Munich); 1994 Oct; 89(10):550-5. PubMed ID: 7808356
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.
    Löw P; Neipel F; Rascu A; Steininger H; Manger B; Fleckenstein B; Kalden JR; Harrer T
    Eur J Med Res; 1998 Oct; 3(10):461-4. PubMed ID: 9753702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The thalidomide comeback.
    HIV Hotline; 1998 May; 8(2):7, 9, 15. PubMed ID: 11365364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature.
    Adeyemi OA; Yeldandi AV; Ison MG
    AIDS Read; 2008 Apr; 18(4):196-8, 201-2, 206-7. PubMed ID: 18472442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study.
    Gastaldi R; Martino P; Gentile G; Cafolla A; Cordone I; Giannini G; Torromeo C; Palmisano L; Picardi V; Andreotti M; Avvisati G; Mandelli F
    Haematologica; 2001 Oct; 86(10):1051-9. PubMed ID: 11602411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future trends in Kaposi's sarcoma and lymphoma.
    Schulz TF
    Int J STD AIDS; 1998; 9 Suppl 1():32-4. PubMed ID: 9874115
    [No Abstract]   [Full Text] [Related]  

  • 40. Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors.
    Blankson JN; Klinzman D; Astemborski J; Thomas DL; Kirk GD; Stapleton JT
    AIDS; 2008 Nov; 22(17):2398-400. PubMed ID: 18981782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.